HORACIO ALVAREZ-GALLARDO

Dr. HORACIO ALVAREZ-GALLARDO

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 November 2021 in Revista Mexicana de Ciencias Pecuarias
Verified
Journal Article
Open access
PDF file
JFJorge Víctor Rosete Fernández
Jorge Víctor Rosete Fernández
HAHORACIO ALVAREZ-GALLARDO
HORACIO ALVAREZ-GALLARDO
DUDavid Urbán-Duarte
David Urbán-Duarte
AIAbraham Fragoso Islas
Abraham Fragoso Islas
MPMarco Antonio Asprón Pelayo
Marco Antonio Asprón Pelayo
JSJosé Fernando De La Torre Sánchez
José Fernando De La Torre Sánchez
A lo largo de cinco secciones, se recapitulan las principales biotecnologías reproductivas en el bovino, se analiza su desarrollo histórico, estado actual, y se incluyen resultados generados en México. En la década de 1970, se inició la sincronización estral e inducción de la ovulación donde, basados en el conocimiento de la fisiología reproductiva bovina, se empezó a controlar el ciclo reproductivo con recursos disponibles en aquel entonces. Con los años, la terapia hormonal evolucionó conforme se descubrieron nuevos compuestos, refinando métodos para estandarizar el efecto y generar nuevos métodos de liberación de las hormonas. La biotecnología más usada en el mundo, la inseminación artificial, debe su expansión a los avances en el procesamiento del semen, donde destaca el desarrollo de diluyentes, la criopreservación, el sexado del semen y el análisis espermático asistido por computadora. La era embrionaria inició con el desarrollo de la multiovulación y los métodos para colectar, evaluar, transferir y criopreservar los embriones. La segunda era embrionaria llegó con la producción de embriones completamente in vitro, partiendo de óvulos inmaduros y semen congelado, en lo que se denominó la producción in vitro de embriones. En ésta, se han invertido grandes recursos de investigación, y materiales, para hacerla un pilar del mejoramiento genético y la productividad, en combinación con otras dos herramientas, el semen sexado y las evaluaciones genómicas. Se vislumbra una época de oro de la producción in vitro de embriones con la posibilidad de modificar el genoma de embriones con precisión, gracias a la tecnología de edición de genes.

7 August 2020 in Reproduction in Domestic Animals
Verified
Journal Article
Closed access
PDF file
FSFroylan Sosa
Froylan Sosa
SRSalvador Romo
Salvador Romo
MKMichael E. Kjelland
Michael E. Kjelland
HAHORACIO ALVAREZ-GALLARDO
HORACIO ALVAREZ-GALLARDO
SPSandra Pérez‐Reynozo
Sandra Pérez‐Reynozo
JSJosé Fernando De La Torre Sánchez
José Fernando De La Torre Sánchez

12 August 2024 in Revista Mexicana de Ciencias Pecuarias
Verified
Journal Article
Open access
PDF file
HAHORACIO ALVAREZ-GALLARDO
HORACIO ALVAREZ-GALLARDO
DUDavid Urbán-Duarte
David Urbán-Duarte
ARAdriana Velázquez Roque
Adriana Velázquez Roque
JSJosé Fernando De La Torre Sánchez
José Fernando De La Torre Sánchez
Desde el inicio comercial del sexado espermático en la inseminación artificial, la adopción de esta tecnología por la industria ganadera (productores, médicos veterinarios y compañías de genética) ha sido una realidad en la producción bovina, principalmente en ganado lechero. La presente revisión, es una descripción de los inicios del sexado espermático, su desarrollo, aplicación a nivel comercial, y evolución hasta la actualidad. Los eventos más significativos fueron sin lugar a dudas la determinación de la diferencia en el contenido de DNA entre los espermatozoides portadores del cromosoma “Y” o “X”, el flujo de estos en el citómetro, y su separación en los así llamados espermatozoides “Y” y “X”. Los siguientes logros que favorecieron la aplicación de esta tecnología de forma comercial fueron la determinación de la concentración óptima y la criopreservación exitosa del semen sexado; desde entonces, las investigaciones para tratar de disminuir los efectos deletéreos del proceso de sexado no se detuvieron, llegando hasta el surgimiento de nuevas tecnologías de sexado espermático donde este efecto es mínimo. La técnica más ampliamente difundida de forma comercial es el ultrasexado de 4 millones de espermatozoides (SexedULTRA-4M™), en la cual se modificaron completamente el método, los medios y los citómetros, con lo que esta tecnología tiene resultados muy similares a los obtenidos con semen no sexado (semen convencional). Existe otra tecnología de sexado espermático llamada Sexcell™ que se oferta de forma comercial, en la cual han obtenido resultados similares a los obtenidos con semen convencional, pero solo en vaquillas. Con estos avances, el sexado espermático se muestra como una tecnología en constante desarrollo y de alto impacto en la ganadería bovina.

1 January 2022 in Animal Reproduction
Verified
Journal Article
Open access
HAHORACIO ALVAREZ-GALLARDO
HORACIO ALVAREZ-GALLARDO
MKMichael Kjelland
Michael Kjelland
MPMario Pérez-Martínez
Mario Pérez-Martínez
FVFernando Villaseñor-González
Fernando Villaseñor-González
SRSalvador Romo-García
Salvador Romo-García
SexedULTRA-4M™ is made using an improved method of sex-sorting sperm in a less damaging environment for better retaining sperm integrity throughout the sorting process. The objective of this research was to compare conventional (CONV) and SexedULTRA-4M™ (ULTRA-4M) semen for bovine IVP using four Angus bulls. Matured slaughterhouse oocytes (n = 4000) were divided into the CONV group and the ULTRA-4M group (2000 COCs for each semen type). The IVF process was implemented with CONV and ULTRA-4M semen from the same bull. The cleavage rates, eight cell embryos and blastocysts on day 7 of culture were evaluated for each semen type and each bull. The statistical analysis was carried out with the ANOVA procedure SAS software. The results were 54.45% ± 1.03 and 58.10% ± 1.07; 35% ± 1.57 and 39.15% ± 1.62; 22.8% ± 1.09 and 27.15% ± 1.12 for CONV and ULTRA-4M, respectively, for cleavage rate, eight cell embryos and blastocysts on day 7 for the average of all bulls, comparing only the semen type. Concerning only the semen type, ULTRA-4M was significantly superior to CONV for cleavage rates (P = 0.01) and blastocysts on day 7 (P = 0.009). There were no significant differences between the CONV and ULTRA-4M groups (P>0.05) for all variables analyzed for Bull 1 and Bull 4, however, for Bull 2 ULTRA-4M was significantly superior to CONV for cleavage rates and blastocysts on day 7 (P< 0.05). In Bull 3, ULTRA-4M was significantly higher (P< 0.05) for blastocysts on day 7 compared to CONV. In conclusion, under the conditions of this research the ULTRA-4M and CONV semen produced similar bovine IVP results overall.

Verified
Journal Article
Open access
PDF file
DUDavid Urbán-Duarte
David Urbán-Duarte
STShuichiro Tomita
Shuichiro Tomita
HSHiroki Sakai
Hiroki Sakai
HSHideki Sezutsu
Hideki Sezutsu
HAHORACIO ALVAREZ-GALLARDO
HORACIO ALVAREZ-GALLARDO
KUKeiro Uchino
Keiro Uchino
The permeation of cryoprotectants into insect embryos is critical for successful cryopreservation. However, the permeability of silkworm embryos to cryoprotectants and the effects of cryopreservation remain poorly studied. In this study, we evaluated the permeability and toxicity of four cryoprotective agents (CPAs) as well as the vitrification effect on the viability of silkworm embryos. Among the four CPAs, propylene glycol (PG) showed the best permeability. Ethylene glycol (EG) and PG were the least toxic CPAs, but glycerol (GLY) and dimethyl sulfoxide (DMSO) were more toxic. Moreover, we examined several factors including the kind and the concentration of CPAs, exposure time, embryonic stage, and silkworm strains. Embryos at the earlier phases of stage 25 were more tolerant to vitrification using EG. We found that over 21% of embryos treated with EG at the early 2 phase of stage 25: 163 h after egg laying (AEL) developed and progressed to serosa ingestion after vitrification and rewarming. The result was the same in other strains as well. Our results are valuable for the development of new cryopreservation protocols of silkworm embryos.

8 January 2021 in Reproduction, Fertility and Development
Verified
Journal Article
Closed access
PDF file
FVF. Villaseñor-González
F. Villaseñor-González
HAHORACIO ALVAREZ-GALLARDO
HORACIO ALVAREZ-GALLARDO
MKMichael Kjelland
Michael Kjelland
AVA. Velázquez-Roque
A. Velázquez-Roque
SRS. Romo
S. Romo
Colour-Doppler ultrasonography (CDU) has been applied for a more detailed examination of the ovary and uterus, mainly local blood flow in ovarian follicles and the corpus luteum (CL). The main use of CDU is for the diagnosis of early pregnancy or the selection of recipients for embryo transfer in cattle; however, this tool can also be used to select oocyte donors according to blood flow to the ovary. The concept is that more blood flow in the ovary is conducive to a healthier intraovarian environment (e.g. higher progesterone levels and removal of reactive oxygen species), yielding higher quality oocytes. The objective of this research was to evaluate in vitro embryo production (IVP) after selection of oocyte donors, considering ovary irrigation before ovum pickup (OPU). The research was carried out in the reproduction laboratory at the Palominos Ranch (Jalisco, México). The oocyte donors (n = 15) were synchronized before each round of OPU using an intravaginal device (1.9 g of progesterone) with oestradiol benzoate (2 mg) and cloprostenol sodium (500 µg) on Day 0, to avoid the presence of a corpus luteum and to synchronize the follicular wave. On Day 6, the intravaginal device was removed and OPU was performed. All Angus breed donors between 3 and 5 years old with a body condition score between 5–6 (scale 1–9, where 1 is extremely thin and 9 is very obese) and were evaluated with transrectal CDU (Sonoscape S2™) with a linear-array probe (7.5 MHz) before the first OPU session only. The oocyte donors were classified subjectively into three categories: low blood flow (LBF, ∼30% ovarian area), median blood flow (MBF, ∼50% ovarian area), and high blood flow (HBF, ∼70% ovarian area) and were submitted to 3 cycles of IVP each (45 total cycles). Semen from a proven bull for IVF was used during all IVP cycles. All oocytes collected from each donor were used in IVF with the same semen in all IVP cycles. The total oocytes collected, and percentages of viable oocytes, cleavage, and blastocysts on Day 7 of culture were evaluated. Statistical analysis was carried out using the GLM procedure of SAS software (version 9.3; SAS Institute Inc.) to evaluate the results of LBF, MBF, and HBF (P-value = 0.05). Total oocyte recovery was 11.28 ± 1.92, 10.06 ± 1.31, and 15.52 ± 1.05 for HBF, MBF, and LBF, respectively, being significantly higher for LBF (P < 0.05). There were no differences in viable oocytes among groups. Cleavage rates were 53.04% ± 3.43 for HBF, 43.18% ± 2.34 for MBF, and 43.69% ± 1.89 for LBF, being significantly higher for HBF (P < 0.05). Percentage of blastocysts on Day 7 was 38.16% ± 3.80 for HBF, 30.11% ± 2.60 for MBF, and 17.78% ± 2.10 for LBF. This value tended to be significantly higher for HBF than MBF, and both were significantly superior to LBF (P < 0.05). In conclusion, under the conditions of this research, although LBF donors had more total recovered oocytes, blastocyst rates were increased in HBF and MBF donors. Therefore, based on the results of the present study, CDU can be a useful tool for the selection of oocyte donors.